Consequences of the corona restrictions for cancer therapy and survivorship (CroKuS) (COVID-19)

Conditions: C33
C34
C50
C18
C19
C20
C61
C81-C96
F32
Malignant neoplasm of colon

Registration Number: DRKS00025155

Lead Sponsor: Deutsches Krebsforschungszentrum (DKFZ)

Brief Summary: An average of 21.9% of respondents reported pandemic-related changes in care, with changes in rehabilitation being the most frequently identified area of care. The majority of respondents attributed changes in their rehabilitation to the increased risk of infection, while capacity constraints were more frequently cited as the reason for change for postponed surgeries. Breast cancer patients were most likely to be affected by changes, while prostate cancer patients were least likely. Approximately 50% of those affected by changes in care reported moderate to high distress at the time of the changes; in addition, health-related quality of life differed compared with respondents without treatment changes in terms of daily life limitations due to the disease and symptom severity. Regarding contact limitations, the most frequently reported limitations were restrictions on contacts in public and with relatives, neighbors, and friends (85% and 76%, respectively). Half of those affected by these restrictions said they suffered very much or quite a bit.

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 2504

Inclusion Criteria

- Living in Baden-Württemberg
- Men and women with 1 of the following primary cancers: Lung cancer [C33-C34], prostate cancer [C61], breast cancer [C50], colorectal cancer [C18-C20], hematooncological disease [C81-C96]
- Age at recruitment 18-85 years
- Diagnosis: 07/2015-06/2020, 1/3 of those with diagnosis 07/2015-06/2019 and 2/3 with diagnosis 07/2019-06/2020
- Not reported to the cancer registry as diseased until 31/12/2020
- Able to give informed consent

Exclusion Criteria

Disagreement to recording of identity data in the cancer registry of Baden-Württemberg, general disagreement to participate in studies, deceased before receiving the study questionnaire, malign secondary cancer [C00-C97 except C44]